SAVANNAH: Savolitinib (savo) plus osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and MET overexpression (OverExp) and/or amplification (Amp) following progressive disease (PD) on osi
Ahn, M- J.;
Kim, T. M.;
Bonanno, L.;
Cheng, S.;
Kim, S- W.;
외 15명
Citations
WEB OF SCIENCE
9
제목
SAVANNAH: Savolitinib (savo) plus osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and MET overexpression (OverExp) and/or amplification (Amp) following progressive disease (PD) on osi
저자
Ahn, M- J.; Kim, T. M.; Bonanno, L.; Cheng, S.; Kim, S- W.; Tiseo, M.; Chu, Q. S. C.; Proto, C.; Sacher, A.; Luo, Y-h.; Baik, C. S.; Bazhenova, L.; Cadranel, J.; Tuan, D. Bao; Narayanan, P.; Yang, J. C. H.; Gont, A.; Haskins, M.; Xu, W.; de Marinis, F.